Enhanced AAV transduction across preclinical CNS models: A comparative study in human brain organoids with cross-species evaluations
Authors:
Open Access
- 28 June 2024
- journal article
- research article
- Published by Elsevier in Molecular Therapy Nucleic Acids
- Vol. 35 (3) , 102264
Abstract
No abstract availableKeywords
This publication has 60 references indexed in Scilit:
- Hepatotoxicity following administration of onasemnogene abeparvovec (AVXS-101) for the treatment of spinal muscular atrophyJournal of Hepatology, 2021
- Cerebral Organoids: A Human Model for AAV Capsid Selection and Therapeutic Transgene Efficacy in the BrainMolecular Therapy - Methods & Clinical Development, 2020
- Intra-CSF AAV9 and AAVrh10 Administration in Nonhuman Primates: Promising Routes and Vectors for Which Neurological Diseases?Molecular Therapy - Methods & Clinical Development, 2020
- Attenuation of Heparan Sulfate Proteoglycan Binding Enhances In Vivo Transduction of Human Primary Hepatocytes with AAV2Molecular Therapy - Methods & Clinical Development, 2020
- Therapeutic AAV Gene Transfer to the Nervous System: A Clinical RealityNeuron, 2019
- Capsid Modifications for Targeting and Improving the Efficacy of AAV VectorsMolecular Therapy - Methods & Clinical Development, 2019
- Intravenous administration of the adeno-associated virus-PHP.B capsid fails to upregulate transduction efficiency in the marmoset brainNeuroscience Letters, 2018
- In vivo tissue-tropism of adeno-associated viral vectorsCurrent Opinion in Virology, 2016
- Spinal projections of the A5, A6 (locus coeruleus), and A7 noradrenergic cell groups in ratsJournal of Comparative Neurology, 2011
- Descending modulation of painNeuroscience & Biobehavioral Reviews, 2004